The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis (Q42666627)
Jump to navigation
Jump to search
scientific article published on September 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis |
scientific article published on September 2001 |
Statements
1 reference
The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis (English)
1 reference
Debove C
1 reference
Zeisser P
1 reference
Salzman PM
1 reference
Powe LK
1 reference
Truffinet P
1 reference
1 September 2001
1 reference
Identifiers
1 reference